Loading...
•
Mar 31, 2023
ResMed Q3 2023 Earnings Report
ResMed's Q3 2023 earnings were announced, with revenue increasing by 29% and operating profit up by 28%.
Key Takeaways
ResMed Inc. reported a strong third quarter in fiscal year 2023, marked by a 29% increase in revenue to $1,116.9 million and a 28% rise in operating profit. The company saw robust growth in device sales, driven by increased production and delivery of cloud-connected flow generator devices, as well as strong performance in mask and patient interfaces businesses. The Software-as-a-Service (SaaS) business also contributed significantly with a 35% revenue increase.
Revenue increased by 29% to $1,116.9 million, or 31% on a constant currency basis.
Income from operations increased 28%; non-GAAP operating profit up 27%.
Diluted earnings per share of $1.58; non-GAAP diluted earnings per share of $1.68.
Software-as-a-Service revenue increased by 35%.
Revenue by Geographic Location
Forward Guidance
No specific forward guidance was provided in the press release.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...